Patients aged @ years or older with advanced pancreatic cancer were randomly assigned ( @:@ ) , via a permutated computer-generated block allocation scheme ( block size of six ) to receive intravenous gemcitabine ( @ mg/m ( @ ) ) on days @ , @ , and @ every @ weeks and oral erlotinib ( @mg ) once daily in combination with either oral metformin or placebo twice daily .